In a previous study, Wanger et al. reported that YM155 inhibited proliferation and induced apoptosis in multiple myeloma cells, and down-regulation of Mcl-1 by YM155 is more important on its anti-cancer effect, rather than survivin [39]. The gene discussed is MCL1; the disease is plasma cell myeloma.